Ataxion Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Ataxion General Information

Description

Developer of novel small-molecule therapeutics designed for neurological diseases. The company's novel small-molecule therapeutics offers a treatment of hereditary ataxia based on ion-channel modulators, enabling patients to treat ataxia associated with other degenerative neurological disorders including multiple sclerosis and huntington's disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 400 Technology Square
  • 10th Floor
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 400 Technology Square
  • 10th Floor
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ataxion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 06-Mar-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Mar-2014 Completed Startup
1. Seed Round 01-Apr-2013 Completed Startup
To view Ataxion’s complete valuation and funding history, request access »

Ataxion Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A1
To view Ataxion’s complete cap table history, request access »

Ataxion Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
Biogen Corporation Minority
Saniona Corporation Minority
To view Ataxion’s complete investors history, request access »

Ataxion FAQs

  • When was Ataxion founded?

    Ataxion was founded in 2013.

  • Where is Ataxion headquartered?

    Ataxion is headquartered in Cambridge, MA.

  • What industry is Ataxion in?

    Ataxion’s primary industry is Drug Discovery.

  • Is Ataxion a private or public company?

    Ataxion is a Private company.

  • What is Ataxion’s current revenue?

    The current revenue for Ataxion is .

  • How much funding has Ataxion raised over time?

    Ataxion has raised $17M.

  • Who are Ataxion’s investors?

    Atlas Venture, Biogen, and Saniona have invested in Ataxion.

  • When was Ataxion acquired?

    Ataxion was acquired on 06-Mar-2017.

  • Who acquired Ataxion?

    Ataxion was acquired by Cadent Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process